Phase I Clinical Trial to Investigate the Safety, Tolerability, Pharmacokinetics of KD101 in Healthy Male Subjects

Summary

To Evaluate the safety and tolerability after KD101 single oral dosing in healthy male subjects To Evaluate the pharmacokinetic property after KD101 single oral dosing in healthy male subjects To Evaluate the effect of food on bioavailability after KD101 single oral dosing in healthy male subjects

Timeline

Start

2013-12

Primary completion

2014-05

Completion

2014-08

Drugs

Indications